UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 304

Sortiert nach

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

Oncogene, 2010-11, Vol.29 (47), p.6280-6293

2010

Volltextzugriff (PDF)

Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy

Current pharmaceutical design, 2007-02, Vol.13 (5), p.463

2007

Volltextzugriff (PDF)

Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function

Cell death and differentiation, 2005-11, Vol.12 (11), p.1429-1438

2005

Volltextzugriff (PDF)

Involvement of RB gene family in tumor angiogenesis

Oncogene, 2006-08, Vol.25 (38), p.5326-5332

2006

Volltextzugriff (PDF)

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Current cancer drug targets, 2010-09, Vol.10 (6), p.600

2010

Volltextzugriff (PDF)

Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

International journal of cancer, 1999-12, Vol.84 (6), p.545-552

1999

Volltextzugriff (PDF)

c-Myc Phosphorylation Is Required for Cellular Response to Oxidative Stress

Molecular cell, 2006-02, Vol.21 (4), p.509-519

2006

Volltextzugriff (PDF)

relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells

British journal of cancer, 2001-12, Vol.85 (12), p.1914-1921

2001

Volltextzugriff (PDF)

Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used

European journal of cancer (1990), 2002-12, Vol.38 (18), p.2455-2462

2002

Volltextzugriff (PDF)

Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma

Clinical cancer research, 2003-11, Vol.9 (14), p.5370-5379

2003

Volltextzugriff (PDF)

Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells

Molecular biology of the cell, 2005-09, Vol.16 (9), p.4153-4162

2005

Volltextzugriff (PDF)

The future of antisense therapy: combination with anticancer treatments

Oncogene, 2003-09, Vol.22 (42), p.6579-6588

2003

Volltextzugriff (PDF)

Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration

Molecular pharmacology, 2004-11, Vol.66 (5), p.1138-1146

2004

Volltextzugriff (PDF)

455 Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90

European journal of cancer supplements, 2010, Vol.8 (5), p.116-117

2010

Volltextzugriff (PDF)

406 The BH4 domain is required for proangiogenic function of bcl-2 protein

European journal of cancer supplements, 2010, Vol.8 (5), p.104-104

2010

Volltextzugriff (PDF)

Inhibition of Leukemia Cell Proliferation by Receptor-Mediated Uptake of c-myb Antisense Oligodeoxynucleotides

Proceedings of the National Academy of Sciences - PNAS, 1992-08, Vol.89 (15), p.7031-7035

1992

Volltextzugriff (PDF)

A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line

European journal of cancer (1990), 2001-11, Vol.37 (17), p.2247-2256

2001

Volltextzugriff (PDF)

p53 Nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy

American journal of clinical pathology, 2001-09, Vol.116 (3), p.360-368

2001

Volltextzugriff (PDF)

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

British journal of cancer, 1994-03, Vol.69 (3), p.463-467

1994

Volltextzugriff (PDF)

62 POSTER Expression and functional activity of interleukin-8 receptors on human malignant melanoma cells

European journal of cancer supplements, 2008, Vol.6 (12), p.22-22

2008

Volltextzugriff (PDF)

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells

European journal of cancer (1990), 2006-08, Vol.42 (12), p.1881-1888

2006

Volltextzugriff (PDF)

Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

British journal of cancer, 2003-09, Vol.89 (6), p.1091-1095

2003

Volltextzugriff (PDF)

Overexpression of transforming growth factor β‐type II receptor reduces tumorigenicity and metastastic potential of K‐ras‐transformed thyroid cells

International journal of cancer, 1999-01, Vol.80 (1), p.85-91

1999

Volltextzugriff (PDF)

44 POSTER The BH4 domain is required for proangiogenic function of bcl-2

European journal of cancer supplements, 2008, Vol.6 (12), p.17-17

2008

Volltextzugriff (PDF)

Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth

Journal of cellular physiology, 2005-12, Vol.205 (3), p.414-421

2005

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(261)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy

Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function

Involvement of RB gene family in tumor angiogenesis

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

c-Myc Phosphorylation Is Required for Cellular Response to Oxidative Stress

relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells

Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used

Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma

Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells

The future of antisense therapy: combination with anticancer treatments

Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration

455 Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90

406 The BH4 domain is required for proangiogenic function of bcl-2 protein

Inhibition of Leukemia Cell Proliferation by Receptor-Mediated Uptake of c-myb Antisense Oligodeoxynucleotides

A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line

p53 Nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

62 POSTER Expression and functional activity of interleukin-8 receptors on human malignant melanoma cells

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells

Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

Overexpression of transforming growth factor β‐type II receptor reduces tumorigenicity and metastastic potential of K‐ras‐transformed thyroid cells

44 POSTER The BH4 domain is required for proangiogenic function of bcl-2

Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth

Suchergebnisse filtern